1. Home
  2. PERI vs PROK Comparison

PERI vs PROK Comparison

Compare PERI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perion Network Ltd.

PERI

Perion Network Ltd.

HOLD

Current Price

$9.36

Market Cap

428.3M

Sector

Technology

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.77

Market Cap

416.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERI
PROK
Founded
1999
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.3M
416.6M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
PERI
PROK
Price
$9.36
$1.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$14.50
$7.40
AVG Volume (30 Days)
517.7K
1.5M
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$893,000.00
Revenue This Year
$9.98
N/A
Revenue Next Year
$2.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1075.00
52 Week Low
$7.63
$1.53
52 Week High
$11.44
$4.95

Technical Indicators

Market Signals
Indicator
PERI
PROK
Relative Strength Index (RSI) 55.59 46.66
Support Level $9.34 $1.63
Resistance Level $9.92 $1.96
Average True Range (ATR) 0.30 0.17
MACD 0.07 -0.01
Stochastic Oscillator 65.79 23.14

Price Performance

Historical Comparison
PERI
PROK

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: